Search

CUREVAC WALKS AWAY FROM ARCTURUS' UREA CYCLE DISORDER DRUG, BUT PARTNERSHIP REMAINS INTACT

Arcturus Therapeutics had a melodramatic 2018 - the San Diego biotech's CEO Joseph Payne was asked to leave for putting his interests...

15 For '19: Key Clinical Data to Watch For Next Year

15 FOR '19: KEY CLINICAL DATA TO WATCH FOR NEXT YEAR

On Monday, Xconomy began our annual look ahead at clinical trials that could define biotech and have profound healthcare effects in...

 
 
 
 
 
 
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact

ELI LILLY TO PURSUE MRNA CANCER VACCINES WITH CUREVAC PACT

Eli Lilly is getting a foothold in messenger RNA cancer vaccines through a deal with CureVac that could develop up to five new therapies....

 
 
 

CUREVAC TO PRESENT AT THE J.P. MORGAN 35TH ANNUAL HEALTHCARE CONFERENCE 2017

TUBINGEN, Germany, Dec. 28, 2016 /PRNewswire/ - CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based...